Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
47.00
+0.37 (0.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
Korro Bio Employees
As of December 31, 2023, Korro Bio had 102 total employees, including 101 full-time and 1 part-time employees.
Employees
102
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$860,863
Market Cap
440.31M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Health Catalyst | 1,300 |
| Pacific Biosciences of California | 796 |
| Quanterix | 441 |
| National Research | 435 |
| Xeris Biopharma Holdings | 377 |
| Esperion Therapeutics | 240 |
| Allogene Therapeutics | 233 |
| OmniAb | 106 |
KRRO News
- 1 hour ago - Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 7 days ago - Korro to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 17 days ago - Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board - GlobeNewsWire
- 7 weeks ago - Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 3 months ago - Korro to Participate in Upcoming September Investor and Scientific Conferences - GlobeNewsWire
- 3 months ago - Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 months ago - Korro to Participate in Upcoming June Investor and Scientific Conferences - GlobeNewsWire
- 6 months ago - Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference - GlobeNewsWire